Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Persoonlijk profiel
Expertise gerelateerd aan duurzame ontwikkelingsdoelstellingen van de VN
In 2015 stemden de VN-lidstaten in met 17 wereldwijde duurzame ontwikkelingsdoelstellingen (Sustainable Development Goals, SDG's) om armoede te beëindigen, de planeet te beschermen en voor iedereen welvaart te garanderen. Het werk van deze persoon draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en):
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Hiddo Lambers Heerspink actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial
Beernink, J., Jongs, N., Doelman, C., Laverman, G. & Heerspink, H., 24-mrt.-2025, In: Jama network open. 8, 3, 11 blz., e251689.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand1 Citaat (Scopus)2 Downloads (Pure) -
Authors' Reply: Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence
Heerspink, H. J. L. & Smeijer, J. D., feb.-2025, In: Journal of the American Society of Nephrology. 36, 2, blz. 324 1 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand14 Downloads (Pure) -
Authors’ Reply: Unlocking the Potential of SC0062: A New Horizon in IgA Nephropathy Treatment?
Chen, J. & Heerspink, H. J. L., apr.-2025, In: Journal of the American Society of Nephrology. 36, 4, blz. 746 1 blz.Onderzoeksoutput › Academic › peer review
-
Canagliflozin and iron metabolism in the CREDENCE trial
Koshino, A., Heerspink, H. J. L., Jongs, N., Badve, S. V., Arnott, C., Neal, B., Jardine, M., Mahaffey, K. W., Pollock, C., Perkovic, V., Hansen, M. K., Bakker, S. J. L., Wada, T. & Neuen, B. L., 1-apr.-2025, In: Nephrology Dialysis Transplantation. 40, 4, blz. 696-706 11 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand15 Downloads (Pure) -
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials
Chatur, S., Vaduganathan, M., Fletcher, R. A., Perkovic, V., Heerspink, H., Arnott, C., Pollock, C., Mahaffey, K. W., Neal, B., Jardine, M., Solomon, S. D. & Neuen, B. L., 23-jan.-2025, (E-pub ahead of print) In: European Journal of Heart Failure.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand1 Citaat (Scopus)6 Downloads (Pure)
Activiteiten
-
The George Institute for Global Health, Sydney
Lambers Heerspink, H. (Visiting researcher)
feb.-2024Activiteit: Visiting an external institution › Professional
-
Supervision of PhD student Abdulfataah Mohamed
Stevens, J. (Co-supervisor), Lambers Heerspink, H. (Supervisor), Gansevoort, R. (Supervisor) & van de Merbel, N. (Co-supervisor)
9-jan.-2022 → 9-jan.-2025Activiteit: Supervision and examination of PhD students of the UG › Academic
-
European Association for the Study of Diabetes (EASD) Barcelona 2019
Lambers Heerspink, H. (Invited speaker)
17-sep.-2019Activiteit: Academic presentation › Academic
-
ASN Kidney week
Lambers Heerspink, H. (Speaker)
7-nov.-2019 → 9-nov.-2019Activiteit: Academic presentation › Academic
-
Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas
Stevens, J. (Speaker) & Heerspink, H. (Speaker)
29-jan.-2019Activiteit: Professional or public presentation › Professional
Datasets
-
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
Eder, S. (Contributor), Leierer, J. (Contributor), Kerschbaum, J. (Contributor), Rosivall, L. (Contributor), Wiecek, A. (Contributor), De Zeeuw, D. (Contributor), Mark, P. B. (Contributor), Heinze, G. (Contributor), Rossing, P. (Contributor), Lambers Heerspink, H. (Contributor) & Mayer, G. (Contributor), University of Groningen, 21-feb.-2018
DOI: 10.6084/m9.figshare.5909164.v1
Dataset
-
Supplementary Material for: Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial
Lam, D. (Contributor), Nadkarni, G. N. (Contributor), Mosoyan, G. (Contributor), Neal, B. (Contributor), Mahaffey, K. W. (Contributor), Rosenthal, N. (Contributor), Hansen, M. K. (Contributor), Lambers Heerspink, H. (Contributor), Fleming, F. (Contributor) & Coca, S. G. (Contributor), figshare Academic Research System, 11-jan.-2022
DOI: 10.6084/m9.figshare.18133754.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Clinical_Utility_of_KidneyIntelX_in_Early_Stages_of_Diabetic_Kidney_Disease_in_the_CANVAS_Trial/18133754/1
Dataset
-
Supplementary Material for: International variability of renal and cardiovascular outcomes and mortality in patients with type 2 diabetes mellitus in Europe
Thöni, S. (Contributor), Keller, F. (Contributor), Denicolò, S. (Contributor), Eder, S. (Contributor), Buchwinkler, L. (Contributor), Rosivall, L. (Contributor), Wiecek, A. (Contributor), Mark, P. B. (Contributor), Rossing, P. (Contributor), Heerspink, H. L. (Contributor) & Mayer, G. (Contributor), Karger Publishers, 4-apr.-2023
DOI: 10.6084/m9.figshare.22233337, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_International_variability_of_renal_and_cardiovascular_outcomes_and_mortality_in_patients_with_type_2_diabetes_mellitus_in_Europe/22233337
Dataset
-
Supplementary Material for: Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Chin, M. P. (Contributor), Bakris, G. L. (Contributor), Block, G. A. (Contributor), Chertow, G. M. (Contributor), Goldsberry, A. (Contributor), Inker, L. A. (Contributor), Lambers Heerspink, H. (Contributor), O'Grady, M. (Contributor), Pergola, P. E. (Contributor), Wanner, C. (Contributor), Warnock, D. G. (Contributor) & Meyer, C. J. (Contributor), University of Groningen, 18-jan.-2018
DOI: 10.6084/m9.figshare.5798001.v1
Dataset
-
Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Lienczewski, C. (Contributor), Karihaloo, A. (Contributor), Kretzler, M. (Contributor), Dutius Andersson, A.-M. (Contributor), Pontrelli, P. (Contributor), Gesualdo, L. (Contributor), Sharma, K. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Shore, A. C. (Contributor), Ibberson, M. (Contributor), Lambers Heerspink, H. (Contributor), Gomez, M. F. (Contributor), Gilchrist, M. (Contributor), Nuutila, P. (Contributor), Teh, I. (Contributor), Mansfield, M. (Contributor), Papale, M. (Contributor), Banks, R. E. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Tobin, K. (Contributor), Metsärinne, K. (Contributor), Zetterqvist, A. (Contributor), Garcia Hernandez, A. (Contributor), De Zeeuw, D. (Contributor), Ball, C. (Contributor), Grenier, N. (Contributor), Saunavaara, V. (Contributor), Maziarz, M. (Contributor), Gilmour, P. S. (Contributor), Shelley, D. (Contributor) & Puppala, S. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586625.v1
Dataset
Knipsels
-
Hoe afslankmedicijnen het hele lichaam veranderen: ‘Mijn hoofd roept niet meer om eten’
29/03/2025
1 Mediabijdrage
Pers / media: Expert Comment › Popular
-
智康弘义宣布SC0062临床II期糖尿病肾病队列研究达到12周主要终点 | 项目进展
25/12/2024
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Diabetesmedicijn Ozempic heeft ook positief effect bij chronische nierschade
25/10/2024 → 08/11/2024
3 items van Media-aandacht, 4 Mediabijdrages
Pers / media: Expert Comment › Popular
-
Semaglutide in patinenten met nierziekte
27/10/2024
1 Mediabijdrage
Pers / media: Expert Comment › Professional
-
BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 wit
14/10/2024
1 item van Media-aandacht
Pers / media: Activiteiten met een maatschappelijk belang › Professional
Prijzen
-
American Society of Nephrology Donald Seldin Young Investigotar LifeTime Award
Lambers Heerspink, H. (Recipient), 2024
Prijs: Prize › Professional
-
-
-